BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Oral Liposomal BPC Tissue Healing Support Supplement BPC 157 for ACL recovery: hype vs. science Adam C. Cady MHS, ATC, CSCS, PA C posted on the topic LinkedIn Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law